FindTrial
Sign In

The Establishment of an Intelligent Magnetic Induction Non-sensory Muscle Group Training Platform to Promote Rehabilitation of Upper Limb Dysfunction in Postoperative Breast Cancer Patientsbilitation of Upper Limb Dysfunction in Postoperative Breast Cancer Patients

The Establishment of an Intelligent Magnetic Induction Non-sensory Muscle Group Training Platform to Promote Rehabilitation of Upper Limb Dysfunction in Postoperative Breast Cancer Patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114577
Enrollment
Unknown
Registered
2025-12-15
Start date
2025-12-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Upper Limb Dysfunction in Breast Cancer

Interventions

Magnetic Induction Stimulation Group:1)Apply magnetic stimulation to the subjects every 48 hours, with each session lasting 15 minutes
2)Treatment duration: 4 weeks.
Exercise Rehabilitation Therapy Group:Regular postoperative rehabilitation exercise guidance provided by clinicians
Combined Exercise Rehabilitation and Magnetic Stimulation Group:1) Regular postoperative rehabilitation exercise guidance provided by clinicians
2) Apply magnetic stimulation to the subjects every 48 hours, with each session lasting 15 minutes
3) Treatment duration: 4 weeks.

Sponsors

The First Affiliated Hospital of Jinzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years; 2. Patients who have undergone surgery for early-stage (Stage I, Stage IIA, or some cases of Stage IIB (T2N1)) or locally advanced breast cancer (including some cases of Stage IIB (T3N0) and Stage IIIA-IIIC); 3. Presence of postoperative upper limb dysfunction; 4. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of neurological, muscular, skeletal, or other diseases leading to restricted shoulder joint movement and upper limb weakness; 2. Preoperative severe cardiac dysfunction, liver dysfunction, renal dysfunction, or coagulation disorder; 3. Abandonment of rehabilitation treatment after surgery; 4. Severe cognitive or emotional disorders hindering cooperation with investigation and rehabilitation assessments; presence of implanted cardiac pacemakers, stents, or metallic foreign bodies.

Design outcomes

Primary

MeasureTime frame
Disabilities of the Arm, Shoulder and Hand (DASH) Score;—

Secondary

MeasureTime frame
Constant-Murley Shoulder Function Score;Shoulder Range of Motion (ROM);Maximal Voluntary Contraction Force of Muscle;—

Countries

China

Contacts

Public ContactZhenhua Zhai

The First Affiliated Hospital of Jinzhou Medical University

zhenhua.zhai@vip.163.com+86 186 4162 1266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026